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Abnormal endometrial function remains a signiﬁcant cause of implantation failure, recurrent pregnancy loss, and other patholo-
gies responsible for female infertility. The development of novel therapies to treat infertility due to endometrial dysfunction
requires an understanding of the latest advancements in endometrial cell biology, such as the role of endometrial stem cells. The
remarkable regenerative capacity of the human endometrium is absolutely essential for successful reproduction and likely requires
a population of stem cells in the endometrium. The purpose of this review is to provide an introduction to some of the newest
concepts in endometrial stem cell biology.
1.Introduction
Successful reproduction in mammalian females requires a
precisely timed and complex interaction between the hypo-
thalamic-pituitary-ovarian (HPO) axis and the uterine en-
dometrium. Although signiﬁcant advances in reproductive
medicine have achieved eﬀective therapies for abnormalities
in the HPO axis, abnormalities in endometrial function re-
main poorly understood. Abnormal endometrial function
remains a signiﬁcant cause of implantation failure, recurrent
pregnancy loss, and other pathologies which lead to female
infertility. Development of eﬀective therapy for infertility
due to endometrial dysfunction requires enhanced under-
standing of the latest advancements in endometrial cell bio-
logy such as the role of stem cells. The purpose of this review
is to provide an introductory guide to understanding some
of the newest concepts in endometrial stem cell biology.
The human endometrium, derived from the mucosal lin-
ing of the fused mesodermal (paramesonephric) tubes (the
m¨ ullerian ducts) during embryogenesis, is a dynamic tissue.
It is comprised of two major zones: (1) the functionalis, a
transient layer containing glands extending from the surface
(luminal) epithelium as well as the supportive stroma, and
(2) the basalis, comprised of the basal region of the glands,
stroma, supporting vasculature, and lymphoid aggregates.
Although various leukocyte cell types populate the endome-
trialstroma,includingTandBcells,mastcells,macrophages,
and neutrophils, the majority of the leukocytes populating
the decidualized endometrium of the late secretory phase
and early pregnancy are phenotypically unique, tissue-spec-
iﬁc lymphocytes known as uterine natural killer (uNK) cells
[1].Thesecellsplayakeyroleintheestablishmentandmain-
tenance of early pregnancy [2]. Yet, despite their well-doc-
umented importance to successful reproduction, their lin-
eage and origin remain unknown.
Human endometrium is unique in its temporally regu-
lated processes of cellular proliferation, diﬀerentiation, and
shedding of the functionalis layer with each menstrual cycle.
The endometrium has the distinctive ability to undergo
physiologic angiogenesis in order to facilitate implantation,
as well as to regenerate an entirely new functionalis layer fol-
lowing each menses. This remarkable regenerative capacity
is essential for successful human reproduction. Although the
mechanisms which allow for it remain poorly understood, it
is likely to require a uterine stem cell population [3–6].
Somatic stem cells have been identiﬁed in many tissue
types, including intestine, skin, and bone marrow, and are
crucial for physiologic tissue renewal and regeneration after
injury [7]. Somatic stem cells are undiﬀerentiated cells, de-
ﬁned by their ability to both self-renew and diﬀerentiate into2 Obstetrics and Gynecology International
mature progeny cells of a given tissue type. Evidence exists to
support the presence of a resident stem cell population in the
uterus, but the location and origin of these cells is unknown
[3–6, 8, 9]. A number of possibilities exist as to the origin of
endometrial stem cells [4, 6, 9]: (1) they may represent fetal
epithelial and mesenchymal stem cells which remain in the
adult endometrium and continue to replicate in adulthood,
(2) they may represent circulating stem cells arising from a
hematogenous source (such as the bone marrow) that seeds
the endometrium either periodically or in response to injury,
or (3) they may represent a combination of the above.
The hypothesis that cyclic regeneration of the endome-
trium is mediated via a resident stem/progenitor cell popula-
tion in the uterus was originally based on early experimental
studies in rhesus monkeys, which revealed that removal of all
visible tissue via endometriectomy was followed by, after a
shortdelay,reconstructionofanewendometrium[10].Clin-
icalobservationsthatsomewomenwhounderwentcomplete
endometrial ablation later developed areas of functional en-
dometrial tissue [11] further supported this hypothesis. Sub-
sequent studies by Padykula et al. [12, 13] provided addi-
tional, albeit indirect, evidence of the existence of an endo-
metrial stem cell compartment. Using [3H]thymidine incor-
poration during the natural menstrual cycle of the rhesus
monkey, these investigators demonstrated that the primate
endometrium possessed a germinal compartment localized
tothelowerbasalis,inwhichhighepithelialactivitypersisted
postovulation and appeared to escape inhibition by proges-
terone. This compartment persisted after menses and was
postulated to give rise to the transient functionalis layer.
These studies, performed in a primate model with menstrual
cycles identical to that of the human, provided the basis for
the hypothesis that the basalis is the location of a stem cell
population in the human endometrium [12, 13].
2.EndometrialStemCells:
Evidence for Their Existence
Adult stem cells in the endometrium are diﬃcult to identify
because they constitute very small populations of cells, and
because cell surface markers speciﬁc for adult stem cells have
notbeendeﬁnitivelycharacterized[4].Studieswhichprovide
indirect evidence for the existence of endometrial stem cells
do so by characterizing cell populations in the endometrium
which exhibit the functional properties of stem cells. These
properties include clonogenicity, proliferative potential, and
capacity for diﬀerentiation into one or more lineages [4].
Such functional assays provide evidence for the existence of
adult stem cells but unfortunately do not allow for localiza-
tion of the cells within a given tissue.
Clonogenicity,deﬁnedastheabilityofasinglecelltopro-
duce a colony when seeded at very low densities, was dem-
onstrated in human endometrium for the ﬁrst time in 2004
[14]. Using puriﬁed single cell suspensions dispersed from
hysterectomy specimens, Chan et al. identiﬁed small pop-
ulations of epithelial (0.22%) and stromal cells (1.25%)
in human endometrium that possessed clonogenic activity
[14]. Large colonies containing >4000 cells were rare and
postula-ted to be initiated by stem/progenitor cells, whereas
the more common small colonies were postulated to be in-
itiated by more mature transit amplifying cells. A more
recent study by these investigators [15] demonstrated that,
for both epithelial and stromal cells, clonogenicity did not
vary by cycle phase or between active (cycling) and inactive
endometrium. The ﬁnding, however, of clonogenic cells in
inactive endometrium further supports the existence of an
endometrial stem cell niche in the basalis, as inactive en-
dometrium is predominantly basalis and lacks functionalis
[15].
Other properties evaluated in characterization of an en-
dometrial stem cell population include the capacity for uni-
or multilineage diﬀerentiation. The diﬀerentiation potential
of candidate stem cells is evaluated after culturing the cells
in diﬀerentiation-induction media, then analyzing the cells
forexpressionofphenotypicdiﬀerentiationmarkers.Gargett
etal.[16]evaluatedproliferativeanddiﬀerentiationpotential
of clonogenic human endometrial cells. Proliferative poten-
tial was assessed by serially passaging individual epithelial
and stromal colony forming units (CFU) until senescence;
large CFU underwent >30 population doublings before se-
nescence, indicating their high proliferative potential char-
acteristic of stem/progenitor cells. Single epithelial CFU dif-
ferentiated into mature glands in vitro, and large secondary
stromal clones demonstrated multipotency as their progeny
diﬀerentiated into smooth muscle cells, adipocytes, chon-
drocytes, and osteoblasts, when cultured in typical diﬀeren-
tiation-induction media. Thus, both epithelial progenitor
cell and multipotent mesenchymal stem cell- (MSC-) like
populations were identiﬁed in human endometrium. MSCs
are multipotent cells located in the bone marrow and mul-
tiple other tissues and have the ability to diﬀerentiate into
cells of multiple mesoderm-derived lineages, such as bone,
cartilage, muscle, and adipose tissue [17]. Similarly, Wolﬀ
et al. [18] demonstrated the presence of multipotent cells in
human endometrium by inducing chondrogenic diﬀerentia-
tion of a subpopulation of endometrial stromal cells in vitro,
identiﬁed by expression of type II collagen and sulfated gly-
cosaminoglycans, characteristic of chondrocytes. It must be
recognized, however, that although these studies provide evi-
dence for the existence of putative endometrial epithelial and
stromal stem cells, diﬀerentiation studies do not rule out the
possibility of dediﬀerentiation of mature stromal cells in the
presence of diﬀerentiation-induction media, a major limita-
tion of the existing human in vitro diﬀerentiation studies.
Another approach used by multiple investigators to iden-
tify and characterize stem cells in the human endometrium
is the isolation of cells with the “side population” phenotype.
Side population cells are characterized by their ability to
exclude the DNA-binding dye Hoechst 33343 by expressing
ATP-binding cassette transporter proteins [19] and exhibit
the properties of adult stem cells including long-term proli-
ferative potential and diﬀerentiation into mature tissue-
speciﬁc cell types. This method has been used to identify pu-
tative stem cell populations in multiple tissues, including
bone marrow [19], liver [20], mammary gland [21], skin
[22], and kidney [23]. More recently, this method has been
utilized for the identiﬁcation and characterization of stem
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from human endometrium have been demonstrated to dis-
play long-term proliferative properties as well as diﬀerentia-
tion into mature endometrial glandular epithelial, stromal,
and endothelial cells both in vitro [24, 25] and in vivo in
immunodeﬁcient mouse models [25–27]. Additional studies
have reported the ability of endometrial side population cells
to diﬀerentiate in vitro into adipocytes and osteocytes, sup-
porting a mesenchymal origin of these cells [26, 28]. Taken
together, thegrowing amount of literature utilizing this tech-
nique, albeit limited to few laboratories worldwide, supports
the hypothesis that side population cells isolated from hu-
man endometrium are indeed somatic stem cells, and that
these cells are a source of mature endometrial cell types.
Although phenotypic markers speciﬁc to endometrial
stem cells have yet to be deﬁnitively identiﬁed, Schwab and
Gargett [29] demonstrated that the perivascular markers
CD146 and PDGF-Rβ enabled isolation of stromal cells from
human endometrium which exhibit phenotypic and func-
tional properties of mesenchymal stem cells (MSCs). The
investigators then used immunohistochemistry to localize
these cells to perivascular areas of the basalis and function-
alis. They hypothesized that these endometrial “MSC-like’’
cells may contribute to cyclic regeneration of the endo-
metrium and further postulated that they may play a role
in the pathogenesis of diseases such as endometriosis and
adenomyosis [29].
3. Localizationof Endometrial Stem Cells:
Mouse Models
Amajorlimitationofthehumanstudiesperformedtodateis
their inability to deﬁnitively identify the origin and location
of candidate stem cells in the endometrium. Investigators
have thus turned to mouse models, using a technique which
takes advantage of the quiescent nature of stem cells. In this
approach, known as the label-retaining cell (LRC) approach,
animals are injected with a thymidine analogue (bromod-
eoxyuridine or BrdU) which becomes incorporated into
genomic DNA during the replication phase of mitosis, and
the tissue of interest is examined for cells which retain this
label after a prolonged chase period due to infrequent cell
divisions (characteristic of somatic stem cells). Using this
technique, Chan and Gargett [30] identiﬁed 3% of epithelial
cells (predominantly luminal) and 6% of stromal cells which
were adjacent to the luminal epithelium at the endometrial-
myometrial junction, as LRC. A subsequent study [31]d e -
tected stromal LRC in a similar location, but none in the
epithelial compartment, after a prolonged chase period. A
more recent study [32] did not evaluate the stromal com-
partmentbutidentiﬁedepithelialLRCspredominantlyinthe
glandular epithelium. Thus, the existing data on the location
of the endometrial stem cell niche in a mouse model are
unclear as to cell type(s) and require further study, but they
support the existence of a small population of uterine stem
cells which are a likely source of regenerative endometrium.
4. The Bone Marrow as a Source of
EndometrialStemCells
Mesenchymal stem cells (MSCs) from the bone marrow have
been demonstrated to diﬀerentiate into mature cell types of
various nonhematopoietic organs including liver, skeletal
muscle, brain, and skin [33]. Recent data from a limited
number of investigators support the concept that bone mar-
row is an important contributor of stem cells to the endo-
metrium. Three independent investigators have identiﬁed
human endometrial stromal, glandular, and/or endothelial
cells of donor bone marrow origin in a total of 8 recipients of
bone marrow transplantation from either HLA-mismatched
[34]o rm a l e[ 35, 36] donors. These ﬁndings were provoca-
tive, supporting the ability of bone marrow-derived cells to
generate endometrial cells de novo. To date, only three inde-
pendent laboratories have reported the use of a murine
bone marrow transplant model to determine whether bone
marrow-derived cells give rise to endometrial parenchymal
cell types. Du and Taylor [37] identiﬁed Y chromosome-
positive endometrial epithelial and stromal cells in female
recipients of bone marrow transplant from male donors six
months post transplant. A similar approach was used by
Mints and colleagues [36], who performed murine bone
marrow transplantation using male donors and identiﬁed
endothelial cells of donor origin in recipient endometria 40
days post transplant. Bratincs´ ak et al. [38]c r e a t e dat r a n s -
genic mouse model in which all CD45+ cells coexpressed
Green Fluorescent Protein and demonstrated that CD45+
hematopoieticprogenitorcellscontributedtouterineepithe-
lium. Collectively, these data, albeit limited, support the hy-
pothesis that the bone marrow is an important source of
endometrial stem cells, exhibiting the capacity to diﬀeren-
tiate into parenchymal and endothelial cell types.
Only one laboratory to date has previously tested the in
vitro capacity of human bone marrow-derived cells to dif-
ferentiateintomatureendometrium.Multipotentmesenchy-
m a ls t e m - l i k ec e l l sw h i c he x p r e s sc e l ls u r f a c em a r k e r st y p i c a l
of bone marrow MSCs have been identiﬁed in human endo-
metrium [16, 29]. Given this line of evidence, Aghajanova
et al. [39] recently tested the ability of human bone marrow-
derivedMSCstodiﬀerentiateintoendometrialdecidualcells.
Human neonatal dermal ﬁbroblasts were used as a control
to determine whether mature ﬁbroblasts could transdiﬀer-
entiate under the same culture conditions. After 14 days of
treatment with 8-bromo-cyclic adenosine monophosphate
(a potent decidualizing agent of human endometrial stromal
cells), human bone marrow-derived MSCs (but not dermal
ﬁbroblasts) displayed morphologic features characteristic of
decidual cells and expressed the classical markers of deci-
dualization, prolactin and IGFBP-1. These studies further
support the bone marrow as a potential precursor of endo-
metrial cells. Whether another major population of bone
marrow-derived cells, lymphohematopoietic stem cells (pre-
cursors of all hematopoietic lineages), are a potential pro-
genitor of human endometrial parenchymal or immune cell
types remains to be investigated. Nonetheless, the concept of
bone marrow-derived endometrial progenitor cells is a pro-
vocative one and bears signiﬁcance not only in mechanisms
underlying normal endometrial physiology but also in disor-
ders of endometrial proliferation, such as endometriosis, en-
dometrial hyperplasia, and endometrial carcinoma. Resident
(as opposed to bone marrow-derived) epithelial and/or
“MSC-like” stem cells may also contribute to such diseases4 Obstetrics and Gynecology International
[4, 6, 8, 40]. Furthermore, the bone marrow as a source of
endometrial cells has therapeutic implications in the treat-
ment of diseases such as Asherman’s syndrome, or poorly
understood disorders of implantation, important causes of
female infertility.
5.UterineNaturalKiller (uNK) Cells
Another major limitation of the uterine stem cell studies
performed to date is that the cellular sources of endometrial
epithelium and stroma have been the predominant focus of
study, with limited attention to the cellular origin of a critical
cell type in endometrial function: the uterine natural killer
(uNK) cell. Phenotypically and functionally diﬀerent from
peripheral NK cells, these cells are crucial in the establish-
ment and maintenance of early pregnancy [2]. They become
abundant in the human uterus 3–5 days post ovulation and
by late secretory phase account for at least 30% of the endo-
metrial stroma [41]. Human in vitro studies provide evi-
dence for the ability of uNK cells to promote placental vas-
cular growth and decidualization via production of chemok-
ines and angiogenic factors [2]. Similarly, murine studies
indicate that uNK cells are essential for induction of spiral
arteries, mediated via their production of IFNγ [42]. Indeed,
the ﬁnding that uNK-deﬁcient mice exhibit compromised
placentation and fetal growth [43] supports a critical role of
theuNKcellinreproductivefunction.However,despitetheir
importance in reproductive function, the cellular origin of
uNK cells remains unclear.
A small number of studies have been performed utilizing
murine bone marrow transplant models and human in vitro
studies, which support the bone marrow as a source of uNK
cells. Peel et al. [44], who performed some of the earliest
studies which provided evidence for bone marrow origin of
uNK cells, utilized a rat-to-mouse bone marrow transplant
model to identify donor-derived uNK cells in deciduomata
of pseudopregnant recipients. Guimond et al. [45] subse-
quently demonstrated in murine studies that bone marrow
transplantation from NK cell-competent to NK cell-deﬁcient
mice led to restoration of the uNK cell population in recipi-
ents as well as restoration of normal decidualization/placen-
tation and fetal viability. Further evidence for a nonuterine
source of uNK cells has been provided by Chantakru et al.
[46], who demonstrated that grafting of uterine segments
from NK cell-competent mice into uNK cell-deﬁcient mice
revealed the absence of uNK cells in the decidualized grafts.
However, transfer of cells from secondary lymphoid tissues
(thymus, spleen, peripheral and mesenteric lymph nodes)
reconstituted the uNK cell population in recipients. More
recently, Vacca et al. [47] demonstrated the ability of CD34+
cells (the phenotype of bone marrow-derived hematopoietic
precursors) present in human decidua to diﬀerentiate in
vitro into uNK cells, either in the presence of certain growth
factors or in coculture with decidual stromal cells. These
uNK cells were functional (producing IL-8 and IL-22,
characteristic products of human uNK cells) and expressed
phenotypic cell surface markers of human uNK cells
(CD56bright/CD16−). However, additional studies, particu-
larlyinhumantissues,areclearlynecessaryinordertoclarify
whether or not the bone marrow represents a signiﬁcant
source of uNK cell precursors.
In summary, additional studies are necessary to provide
us with an enhanced understanding of the capabilities and
limitations of endometrial stem cells to determine the poten-
tial therapeutic uses for these cells.
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